2025-01-20
Background: Sarah is a 32-year-old obese woman with a BMI of 34. Although she does not have diabetes, she has struggled with weight management. Zhang's doctor advised her to consider Tirzepatide as a weight loss medication.
Treatment: Sarah started receiving Tirzepatide injections. After three months, she had lost about 8 kilograms, and the weight loss was steady and sustained. She also said that she felt less appetite at the beginning of the drug, increased satiety after meals, and significantly reduced food intake.
Results: In addition to weight loss, Sarah also reported an increase in overall energy levels, as well as more regular exercise habits. Her weight loss has led to significant psychological and physical improvements, and Sarah is more confident and plans to continue using Tirzepatide to maintain the weight loss.